TABLE 3.

IC₅₀ values of the small molecule kinase inhibitors used in this study on the KAIMRC1 cell line

Inhibitors	Category	Pathways	IC50
FPA124	Kinase inhibitors	Akt	42.13
10‐DEBC hydrochloride		mTOR/Akt	11.63
API‐2		Akt	0.88
AG490		JAK2/STAT	21.10
ZM449829		STAT5	12.78
Thioridazine hydrochloride	Stem cell modulator	mTOR/Akt/PI3K	10.42
KU55933	Epigenome	mTOR	29.33
L002		STAT3	10.4
Mitoxantrone	Topoisomerase II inhibitor	Antineoplastic agent	0.36
Doxorubicin		Anthracycline	0.24
Ruxolitinib	Kinase inhibitors	JAK1 and JAK2	0.94